Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine Search
Carpmaels & Ransford expands life sciences partnership
Europe
Double promotion includes patent attorney who challenged Novartis in G1/22 | Supplementary Protection Certificates expert also joins partnership.   2 July 2024
Report reveals boom in digital health patents
Big Pharma
Clarivate analysis identifies 140,000 patented inventions in digital health in decade to 2022 | Patentees comprise a ‘surprising mix’ of companies across various industries.   2 July 2024
Dority & Manning life sciences head joins WBD
Americas
Womble Bond Dickinson’s new South Carolina partner previously led Dority & Manning’s chemical and life sciences group.   27 June 2024
Americas
Judges considered Hikma’s label and marketing material when overturning lower court’s decision | Court said Amarin had stated plausible claim for induced infringement of patents.   27 June 2024
Americas
US drugmaker files six lawsuits over compounded tirzepatide products | At least five deaths associated with ‘generic’ Mounjaro, according to complaint | Fears over drug's 'unapproved' use for cosmetic weight loss.   25 June 2024
Big Pharma
UK judge concludes neither party has ‘won’ in case between Salts and Pelican over ostomy products | Court denied Salts’ request for Model D disclosure.   25 June 2024
Americas
Magistrate stand-in not authorised to answer jury questions, says eleventh circuit in precedential opinion | Florida judge left to catch flight before verdict given | Dispute between shrimp breeders concerns “unique” breeding method.   20 June 2024
Americas
South Korean firm has sued two manufacturers in Delaware alleging patent infringement | SKBP asked court to stop ANDAs from Aurobindo and Zenara until patents expire.   19 June 2024
Big Pharma
Judge says lower court abused discretion when issuing injunction | Negative impact of potential Medtronic deal on Insulet was “mere conjecture”.   18 June 2024
Big Pharma
New Jersey court grants 30-day stay days after ordering the removal of five patents for asthma inhalers from FDA Orange Book | Decision follows ruling favouring Amneal Pharmaceuticals, which argued the patents were improperly listed.   18 June 2024